| Mitsuokella| Mitsuokella Shah and Collins 1983
Commensal gut bacterium: Mitsuokella is considered a commensal bacterium, meaning it typically resides in the gut microbiota of humans and animals without causing harm under normal conditions. Commensal bacteria play important roles in maintaining gut health, such as aiding in digestion, producing beneficial metabolites, and modulating the immune system.
Fermentation: Like other members of the family Veillonellaceae, Mitsuokella is known for its fermentative metabolism. It can metabolize various dietary carbohydrates, such as lactate, succinate, and pyruvate, producing short-chain fatty acids (SCFAs) as metabolic byproducts. SCFAs, particularly acetate, propionate, and butyrate, serve as an energy source for colonic epithelial cells and have been associated with various health benefits, including gut barrier function, immune regulation, and anti-inflammatory effects.
Role in gut dysbiosis: While Mitsuokella is generally considered part of the normal gut microbiota, alterations in its abundance or composition may occur in certain disease states or conditions associated with gut dysbiosis. Dysbiosis refers to an imbalance in the gut microbial community that is linked to various gastrointestinal disorders, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and colorectal cancer. Changes in the relative abundance of Mitsuokella and other gut bacteria may contribute to the pathogenesis or progression of these conditions.
Potential probiotic properties: Some strains of Mitsuokella may exhibit probiotic properties, meaning they have the potential to confer health benefits when consumed in adequate amounts. Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. While research on the probiotic potential of Mitsuokella is limited, certain strains may possess characteristics that make them suitable candidates for use as probiotics, such as acid and bile tolerance, adherence to intestinal epithelial cells, and antimicrobial activity against pathogens.
Metabolic disorders and obesity: Emerging evidence suggests that alterations in the gut microbiota composition, including changes in the abundance of Mitsuokella and other bacteria, may be associated with metabolic disorders such as obesity and type 2 diabetes. While the specific role of Mitsuokella in metabolic health is not well-understood, its interactions with other gut microbes and host physiology may influence metabolic processes and contribute to the development or progression of metabolic diseases.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.79 | 10 | 16556 | 0 | 12587 | 2272.9 | 80 | 5262.2 | 10 | 16556 | 0 %ile | 100 %ile | ||
biomesight | 39.77 | 0 | 20 | 10 | 6170 | 0 | 7176 | 546.9 | 40 | 3382.4 | 0 | 140 | 3.6 %ile | 97.7 %ile |
thryve | 8.12 | 0 | 0 | 1 | 15757 | 0 | 7028 | 1439.7 | 34 | 2851.2 | 2 | 2538 | 0 %ile | 100 %ile |
ubiome | 2.28 | 23 | 214652 | 0 | 134061 | 28783.6 | 7828 | 53712.9 | 23 | 214652 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 42.563 % | 0.057 % | 0.362 % | 1262.0 | 2965 |
BiomeSightRdp | 61.29 % | 0.039 % | 0.081 % | 19.0 | 31 |
bugspeak | 100 % | 0.005 % | % | 1.0 | 1 |
CosmosId | 3.125 % | 0.003 % | % | 1.0 | 32 |
custom | 3.279 % | 0.052 % | 0.067 % | 2.0 | 61 |
SequentiaBiotech | 5.556 % | 1.656 % | 0 % | 2.0 | 36 |
Thryve | 7.615 % | 0.162 % | 0.302 % | 106.0 | 1392 |
uBiome | 2.273 % | 2.878 % | 5.371 % | 18.0 | 792 |
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.